The fifth plant of OTCPharm is under construction in the Khrabrovo Industrial Park (Kaliningrad region). Of the 40 drugs manufactured by the pharmaceutical holding with the participation of Pharmstandart, 19 are going to be produced here. This was described by www.newkaliningrad.ru (Novyi Kaliningrad).
At a round table on the investment attractiveness of the Kaliningrad region, a representative of Otisipharm said that the new plant would produce the brands most advertised on television, including Arbidol, Aphobazol, Next and Maxicold.
According to the company, the launch of the plant is scheduled for November 2022. When placing production facilities in the Kaliningrad region, the pharmaceutical holding was primarily motivated by the customs and tax benefits available in the region.
Earlier it became known that a new pharmaceutical enterprise will open in the Kaliningrad region.